[250 Pages Report] The China spinal fusion market is expected to register double-digit growth during the forecast period. There are several aspects impacting medical device technology nowadays and demand for spinal fusion devices is likely to rise due to the favourable reimbursement levels and patients’ choice to undergo surgery with minimally invasive techniques
A number of trends including consolidation, research and developments, and international strategies and alliances are driving the demand for spinal fusion devices in China.
Spinal fusion is one of the most common surgeries suggested for back problems and the increasing spinal fusion surgery volumes in China is expected to foster the sales of spinal fusion devices.
Demand for spinal fusion devices will spike owing to the wide variety of applications catering to patients suffering from a number of conditions such as deformity, scoliosis, disc disease, and fracture.
The increasing adoption rate of minimally invasive spinal surgeries, as well as the rising incidences of obesity and degenerative spinal conditions, are surging the demand for spinal fusion devices in China.
The emerging China spinal fusion market has been experiencing a phase of new product development and technological advancements due to greater demand for spinal fusion devices.
The demand for spinal fusion devices will continue to be fuelled by the adoption of 3D-printed implants.
The use of advanced navigation technology (computer-assisted, image-guidance) in spinal surgical procedures aided the growth of the China spinal fusion market to a considerable extent thereby increasing the sales of spinal fusion devices.
Moreover, the increased adoption of advanced robotics in hospitals and the rising number of surgical procedures are expected to drive up the sales of spinal fusion devices in China in the coming years.
Surgeons can now place spine devices with greater efficiency, accuracy, and precision on account of these new technologies, in turn advancing the China spinal fusion market.
Leading manufacturers are concentrating their efforts on developing cutting-edge spine devices thereby expanding the China spinal fusion market share.
The procedures are highly benefited from the investment in the new technologies and their clinical success which is gaining more and more importance in recent days and causing the China spinal fusion market to grow.
The manufacturing companies are raising their respective China spinal fusion market share with aggressive marketing activities and increased R&D activities.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A major factor subsidizing the growth of China's spinal fusion market is the increasing rate of an ageing population with spine-related diseases & related injuries which results in high demand for spinal fusion devices.
Sales of spinal fusion devices are likely to spike owing to the rising incomes of the Chinese populace ensuring the patients’ capability to pay for the treatment.
Demand for spinal fusion devices goes up as the price-sensitive population of China is very responsive to the treatment price that will drip due to the increasing competition in the market, in turn scaling up the sales of spinal fusion devices.
Existing and upcoming advanced technologies and better implant materials are pushing forward the demand for spinal fusion devices, including the younger adult populace and thereby fuelling the China spinal fusion market.
Another factor driving the China spinal fusion market is increased access as the initiatives by the Chinese government facilitate the treatment of a large number of untreated spinal disease patients thereby spiking the sales of spinal fusion devices.
Demand for spinal fusion devices likely drips despite being a widely used procedure for curing extremely debilitating diseases related to the spine, and spinal deformities, as the China spinal fusion market is facing some challenges like reimbursement cuts.
Besides that, sales of spinal fusion devices are also expected to go down on account of heavy government regulations, and high surgery cost.
Risk factors involved in the surgery also act as a significant impediment to the China spinal fusion market, in turn dwindling the sales of spinal fusion devices.
Due to high competition in the market, prices for bone graft substitutes and spinal implants are expected to come down in the Asia Pacific market, thus restraining the China spinal fusion market from growing.
Some of the other growth restraining factors of the China spinal infusion market and sales of spinal fusion devices can be growing awareness for some other treatment methods such as IDET, artificial disc, posterior dynamic stabilization, etc.
Principal Consultant
Some of the key players in the China spinal fusion market are Trauson, Depuy Synthes Companies, Biomet, Inc., Medtronic, Inc, and Nuvasive Inc.
Stryker Corporation, Zimmer Holding, Inc., Orthofix International N.V., B. Braun Aesculap and Weigao Orthopaedic Device Co., Ltd. are a few of the other major China spinal fusion market companies.
The report consists of key players, contributing to the China spinal fusion market share. It also consists of organic and inorganic growth strategies adopted by market players to augment their China spinal fusion market share. This exclusive report analyzes the competitive landscape and China's spinal fusion market share acquired by players to strengthen their market position.
| Report Attributes | Details |
|---|---|
| Base year for estimation | 2021 |
| Historical data | 2015 to 2020 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD Million, volume in kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | Stryker Corporation; Zimmer Holding, Inc.; Orthofix International N.V; B. Braun Aesculap and Weigao Orthopaedic Device Co., Ltd. |
| Customization scope | Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In 2020, China spinal fusion market was worth $665 million.
A few key players include Trauson, Depuy Synthes Companies, Biomet, Inc., Medtronic, Inc, Nuvasive Inc.
Sales of spinal fusion devices spike on account of increasing adoption rate of minimally invasive spinal surgeries.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. China Spinal Fusion Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. China Spinal Fusion Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Interbody Cages
5.3.2. Pedicle Screws and Rods
5.3.3. Spinal Fusion Plates
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 Deep-dive segmentation will be available in the sample on request
6. China Spinal Fusion Market Analysis 2017-2021 and Forecast 2022-2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032
6.3.1. Hospitals
6.3.2. Specialty Clinics
6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
6.5. Absolute $ Opportunity Analysis By End User, 2022-2032 Deep-dive segmentation will be available in the sample on request
7. China Spinal Fusion Market Analysis 2017-2021 and Forecast 2022-2032, By Procedure Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Procedure Type, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Procedure Type, 2022-2032
7.3.1. Poster Lateral Fusion
7.3.2. Interbody Fusion
7.4. Y-o-Y Growth Trend Analysis By Procedure Type, 2017-2021
7.5. Absolute $ Opportunity Analysis By Procedure Type, 2022-2032 Deep-dive segmentation will be available in the sample on request
8. China Spinal Fusion Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
8.3.1. China
8.4. Market Attractiveness Analysis By Region
9. China Spinal Fusion Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. China
9.2.2. By Product Type
9.2.3. By End User
9.2.4. By Procedure Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.3.4. By Procedure Type
9.4. Key Takeaway
10. Key Countries China Spinal Fusion Market Analysis
10.1. China
10.1.1. Pricing Analysis
10.1.2. Market Share Analysis, 2021
10.1.2.1. By Product Type
10.1.2.2. By End User
10.1.2.3. By Procedure Type
11. Market Structure Analysis
11.1. Competition Dashboard
11.2. Competition Benchmarking
11.3. Market Share Analysis of Top Players
11.3.1. By Regional
11.3.2. By Product Type
11.3.3. By End User
11.3.4. By Procedure Type
12. Competition Analysis
12.1. Competition Deep Dive
12.1.1. Medtronic Plc.
12.1.1.1. Overview
12.1.1.2. Product Portfolio
12.1.1.3. Profitability by Market Segments
12.1.1.4. Sales Footprint
12.1.1.5. Strategy Overview
12.1.1.5.1. Marketing Strategy
12.1.1.5.2. Product Strategy
12.1.1.5.3. Channel Strategy
12.1.2. DePuy Synthes
12.1.2.1. Overview
12.1.2.2. Product Portfolio
12.1.2.3. Profitability by Market Segments
12.1.2.4. Sales Footprint
12.1.2.5. Strategy Overview
12.1.2.5.1. Marketing Strategy
12.1.2.5.2. Product Strategy
12.1.2.5.3. Channel Strategy
12.1.3. Zimmer Biomet Holdings, Inc.
12.1.3.1. Overview
12.1.3.2. Product Portfolio
12.1.3.3. Profitability by Market Segments
12.1.3.4. Sales Footprint
12.1.3.5. Strategy Overview
12.1.3.5.1. Marketing Strategy
12.1.3.5.2. Product Strategy
12.1.3.5.3. Channel Strategy
12.1.4. Stryker Corporation
12.1.4.1. Overview
12.1.4.2. Product Portfolio
12.1.4.3. Profitability by Market Segments
12.1.4.4. Sales Footprint
12.1.4.5. Strategy Overview
12.1.4.5.1. Marketing Strategy
12.1.4.5.2. Product Strategy
12.1.4.5.3. Channel Strategy
12.1.5. K2M, Inc.
12.1.5.1. Overview
12.1.5.2. Product Portfolio
12.1.5.3. Profitability by Market Segments
12.1.5.4. Sales Footprint
12.1.5.5. Strategy Overview
12.1.5.5.1. Marketing Strategy
12.1.5.5.2. Product Strategy
12.1.5.5.3. Channel Strategy
12.1.6. Integra Lifesciences Holdings Corp
12.1.6.1. Overview
12.1.6.2. Product Portfolio
12.1.6.3. Profitability by Market Segments
12.1.6.4. Sales Footprint
12.1.6.5. Strategy Overview
12.1.6.5.1. Marketing Strategy
12.1.6.5.2. Product Strategy
12.1.6.5.3. Channel Strategy
12.1.7. MicroPort Scientific Corporation
12.1.7.1. Overview
12.1.7.2. Product Portfolio
12.1.7.3. Profitability by Market Segments
12.1.7.4. Sales Footprint
12.1.7.5. Strategy Overview
12.1.7.5.1. Marketing Strategy
12.1.7.5.2. Product Strategy
12.1.7.5.3. Channel Strategy
12.1.8. NuVasive, Inc.
12.1.8.1. Overview
12.1.8.2. Product Portfolio
12.1.8.3. Profitability by Market Segments
12.1.8.4. Sales Footprint
12.1.8.5. Strategy Overview
12.1.8.5.1. Marketing Strategy
12.1.8.5.2. Product Strategy
12.1.8.5.3. Channel Strategy
12.1.9. Orthofix International N.V.
12.1.9.1. Overview
12.1.9.2. Product Portfolio
12.1.9.3. Profitability by Market Segments
12.1.9.4. Sales Footprint
12.1.9.5. Strategy Overview
12.1.9.5.1. Marketing Strategy
12.1.9.5.2. Product Strategy
12.1.9.5.3. Channel Strategy
12.1.10. Globus Medical, Inc.
12.1.10.1. Overview
12.1.10.2. Product Portfolio
12.1.10.3. Profitability by Market Segments
12.1.10.4. Sales Footprint
12.1.10.5. Strategy Overview
12.1.10.5.1. Marketing Strategy
12.1.10.5.2. Product Strategy
12.1.10.5.3. Channel Strategy
12.1.11. RTI Surgical, Inc
12.1.11.1. Overview
12.1.11.2. Product Portfolio
12.1.11.3. Profitability by Market Segments
12.1.11.4. Sales Footprint
12.1.11.5. Strategy Overview
12.1.11.5.1. Marketing Strategy
12.1.11.5.2. Product Strategy
12.1.11.5.3. Channel Strategy
12.1.12. CoreLink
12.1.12.1. Overview
12.1.12.2. Product Portfolio
12.1.12.3. Profitability by Market Segments
12.1.12.4. Sales Footprint
12.1.12.5. Strategy Overview
12.1.12.5.1. Marketing Strategy
12.1.12.5.2. Product Strategy
12.1.12.5.3. Channel Strategy
12.1.13. B. Braun Melsungen AG
12.1.13.1. Overview
12.1.13.2. Product Portfolio
12.1.13.3. Profitability by Market Segments
12.1.13.4. Sales Footprint
12.1.13.5. Strategy Overview
12.1.13.5.1. Marketing Strategy
12.1.13.5.2. Product Strategy
12.1.13.5.3. Channel Strategy
12.1.14. Precision Spine, Inc.
12.1.14.1. Overview
12.1.14.2. Product Portfolio
12.1.14.3. Profitability by Market Segments
12.1.14.4. Sales Footprint
12.1.14.5. Strategy Overview
12.1.14.5.1. Marketing Strategy
12.1.14.5.2. Product Strategy
12.1.14.5.3. Channel Strategy
12.1.15. Shandong Weigao Group Medical Polymer
12.1.15.1. Overview
12.1.15.2. Product Portfolio
12.1.15.3. Profitability by Market Segments
12.1.15.4. Sales Footprint
12.1.15.5. Strategy Overview
12.1.15.5.1. Marketing Strategy
12.1.15.5.2. Product Strategy
12.1.15.5.3. Channel Strategy
12.1.16. Bonovo Orthopedics, Inc
12.1.16.1. Overview
12.1.16.2. Product Portfolio
12.1.16.3. Profitability by Market Segments
12.1.16.4. Sales Footprint
12.1.16.5. Strategy Overview
12.1.16.5.1. Marketing Strategy
12.1.16.5.2. Product Strategy
12.1.16.5.3. Channel Strategy
12.1.17. ChoiceSpine, LP
12.1.17.1. Overview
12.1.17.2. Product Portfolio
12.1.17.3. Profitability by Market Segments
12.1.17.4. Sales Footprint
12.1.17.5. Strategy Overview
12.1.17.5.1. Marketing Strategy
12.1.17.5.2. Product Strategy
12.1.17.5.3. Channel Strategy
12.1.18. Life Spine, Inc.
12.1.18.1. Overview
12.1.18.2. Product Portfolio
12.1.18.3. Profitability by Market Segments
12.1.18.4. Sales Footprint
12.1.18.5. Strategy Overview
12.1.18.5.1. Marketing Strategy
12.1.18.5.2. Product Strategy
12.1.18.5.3. Channel Strategy
13. Assumptions & Acronyms Used
14. Research Methodology
Explore Healthcare Insights
View Reports
China Spinal Fusion Market
